摘要 |
A process for treating neuropathy includes administration to a patient suffering from a neuropathy more than 5 and less than 18 mg of 4-aminopyridine in a dose. The 4-aminopyridine is formulated in an immediate release formulation. At least two such doses are provided per day to create spike serum plasma levels of 4-aminopyridine sufficient to drive the 4-aminopyridine across the blood-nerve barrier.
|